This is our second episode recorded at the Materialise conference.  Our guest for this episode is no other than the CEO of Materialise Brigitte de Vet-Veithen. It is a pleasure for me to be able to conduct this interview, because Materialise is such a legendary company that has spent 35 years building the software and services infrastructure behind patient-specific implants, surgical planning, and point-of-care manufacturing. We also got to know Brigitte as a person and the new leader of the company. Importantly, we covered the metrics that signal adoption, challenges to scale beyond the halo case, and her vision for the industry.  In my opinion, this is perhaps one of the most important conversations for the medical 3D printing industry in 2026.Highlights of this episode:• Brigitte's journey from MedTech leadership to being the CEO at Materialise• Why reimbursement is the clearest signal of adoption for medical 3D printing• Building health economics evidence for patient-specific devices when every case is unique• Helping physicians shift mindset toward pre-operative planning and new workflows• The move from “3D printing company” to solution partner for specific clinical needs• Why robots and surgical guides coexist, especially in ambulatory surgery centers• How AI compresses lead times and expands access for trauma patients• Mass personalization roadmap across orthopedics, CMF, pediatrics, respiratory, and structural heart• Global adoption differences and why imaging availability sets the pace• Investment priorities across education, evidence generation, R&D, and M&APlease listen to the disclaimer at the end of this podcast.Show Notes: https://3dheals.com/episode-114-interview-with-brigitte-de-vet-veithen-ceo-of-materialise/YouTube: https://youtu.be/9PgME2RAmog?si=t-0X_DkrBdRg4MHeSend us Fan MailSupport the showSubscribe to our premium version and support the show. Follow us: Twitter  Instagram Linkedin 3DHEALS WebsiteFacebookFacebook GroupYoutube channelAbout Pitch3D